CRC Research Update — August 20, 2026
Today's colorectal cancer research highlights
precancer
A collection of 138 issues
WhatsApp chatbot outreach improves colorectal cancer screening uptake
Skip to content
The CRC Digest
▪ SCREENING
WhatsApp chatbot outreach improves colorectal cancer screening uptake
A randomized controlled trial found that a theory-based WhatsApp chatbot delivering health education and personalized risk assessment improved CRC screening uptake rates compared to standard text reminders in asymptomatic individuals aged 50-75. (Clin Gastroenterol Hepatol)
Risk-adapted FIT screening intervals may personalize colorectal cancer screening
Skip to content
The CRC Digest
▪ SCREENING
Risk-adapted FIT screening intervals may personalize colorectal cancer screening
A modeling study based on the BLITZ cohort suggests that screening intervals for fecal immunochemical tests could be tailored based on quantitative hemoglobin levels in initially negative tests, stratifying participants into low, medium, and
CRC Research Update — August 18, 2026
Today's colorectal cancer research highlights
Low Cancer Risk After Negative Colonoscopy Following Positive Stool DNA Test
Skip to content
The CRC Digest
Low Cancer Risk After Negative Colonoscopy Following Positive Stool DNA Test
Community practice data show that patients with a positive multitarget stool DNA test but negative colonoscopy had low rates of subsequent aerodigestive cancers. (Clinical and Translational Gastroenterology)
This content is informational only and
FIT Performance Evaluated for Screening Younger Adults
Skip to content
The CRC Digest
FIT Performance Evaluated for Screening Younger Adults
A multicutoff analysis examined how fecal immunochemical testing performs for colorectal cancer screening in people under 50. (Clinical Colorectal Cancer)
This content is informational only and does not constitute medical advice.
Always consult your oncologist or care
CRC Research Update — August 15, 2026
Today's colorectal cancer research highlights
Multitarget stool DNA test shows promise over standard FIT screening
Skip to content
The CRC Digest
▪ SCREENING
Multitarget stool DNA test shows promise over standard FIT screening
A systematic review found that multitarget stool DNA (mt-sDNA) testing emerged as a promising alternative to faecal immunochemical test (FIT) for detecting colorectal neoplasms, particularly given FIT's low sensitivity for advanced
CRC Research Update — August 14, 2026
Today's colorectal cancer research highlights
Anorectal Visits Offer Missed Screening Opportunity for Adults Under 50
Skip to content
The CRC Digest
▪ SCREENING
Anorectal Visits Offer Missed Screening Opportunity for Adults Under 50
Among 776 patients seen for benign anorectal conditions, only 60.5% of adults aged 45-49 had undergone colonoscopy in the prior 10 years, highlighting a missed opportunity to promote screening during routine visits.